| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $624.0M | +14.8% |
| Cost of Revenue | $267.8M | +8.1% |
| Gross Profit | $356.2M | +20.4% |
| R&D Expense | $162.7M | +17.9% |
| SG&A Expense | $110.7M | -2.4% |
| Operating Income | -$119.0M | +29.1% |
| Interest Expense | $12.6M | +447.8% |
| Pre-tax Income | -$119.2M | +23.3% |
| Income Tax | $2.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $180.6M | -36.9% |
| Short-term Investments | $181.2M | +1766.7% |
| Accounts Receivable | $118.0M | +1.8% |
| Current Assets | $506.7M | +15.1% |
| Total Assets | $1.50B | +3.3% |
| Current Liabilities | $194.0M | +85.7% |
| Long-term Debt | $323.3M | -4.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $94.4M | +475.7% |
| Capital Expenditures | $28.7M | +177.8% |
| Investing Cash Flow | -$213.0M | -219.1% |
| Financing Cash Flow | $12.8M | +174.6% |
| Free Cash Flow | $65.8M | +982.1% |
| -4.5% |
| Net Income | -$121.7M | +23.0% |
| EPS (Basic) | -$0.83 | +27.2% |
| EPS (Diluted) | -$0.83 | +27.2% |
| Total Liabilities |
| $569.9M |
| +17.2% |
| Stockholders' Equity | $929.6M | -3.7% |